Wells Fargo upgraded iRhythm (IRTC) to Overweight from Equal Weight with a price target of $130, up from $104. The firm says strong trends in iRhythm’s underlying business support upside to the company’s raised guidance. iRhythm remains confident in its regulatory remediation plan and that the Zio MCT path to approval should not be impacted, the analyst tells investors in a research note. Wells believes the record new account openings in prior quarters, strong Zio AT unit volume growth that mangement believes is durable, good progress with value-based care accounts, and “healthy” order trends among Epic Aura accounts support upside to iRhythm’s guidance in 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue